Date: 2024-09-03
Location: Kuala Lumpur, Malaysia

         Against the backdrop of the booming global health industry, our company, Shenzhen Marcy Healthy Industry Co., Ltd, has taken a solid step forward in promoting the internationalization of medical and health innovation and technology. Yesterday, our CEO, Mr. Da, and his delegation traveled to Kuala Lumpur, the capital of Malaysia, and had a fruitful meeting with the honorable prince of Malaysia, and had an in-depth discussion on the joint establishment of the "Global Health Industry Group Malaysia Sdn. BHD." and the application for the pharmaceutical patent for Semaglutide.

        This meeting not only marks the formal establishment of the cooperative relationship between the two parties, but also an active exploration of a new model of cooperation in the global health industry. The Malaysian prince highly appreciated our company's innovative achievements in the field of medicine and health, and emphasized the Malaysian government's high attention to the introduction of advanced medical technology and the promotion of the development of the local health industry. The two sides reached a consensus on how to use their respective advantages to jointly promote the research and development, production and market promotion of innovative drugs such as Semaglutide in Malaysia and even Southeast Asia.
         As a new type of GLP-1 receptor agonist, semaglutide has shown excellent efficacy and safety in the field of diabetes and weight loss treatment, and its market potential is huge. As one of the developers and producers of this drug, our company has been committed to promoting it to the global market to benefit more patients. This meeting with the Malaysian prince has undoubtedly laid a solid foundation for the patent registration and market promotion of our semaglutide in Malaysia and Southeast Asia.
        Mr. Da said in the meeting: "We are very honored to work with the Malaysian government and the honorable prince to jointly promote the development of the global health industry. As our company's star product, the successful registration and promotion of semaglutide will not only benefit patients in Malaysia and Southeast Asia, but will also further consolidate our leading position in the global medical and health field."
In the future, our company will work closely with Malaysian partners to accelerate the patent registration process of semaglutide in Malaysia, and explore the establishment of production bases, R&D centers and other cooperative projects to jointly promote the industrialization process of this drug in the local area. At the same time, the two sides will also conduct in-depth discussions on other potential areas of cooperation, striving to achieve mutual benefit and win-win results in a wider range of health industry fields.
        This meeting is not only an important milestone in our company's internationalization strategy, but also a new starting point for cooperation between China and Malaysia in the field of medicine and health. We firmly believe that with the joint efforts of both sides, the global health industry will usher in a more prosperous future.
Company name: Shenzhen Marcy Healthy Industry Co., Ltd
Our product business scope: Semaglutide, Sex Doll Toy, TPE Sex Doll, Silicone Sex Doll, Sucking Tongue Vibrator, Wearable Vibrator Toy and so on.
Contact: logan@cn-alostar.com, +0086 13554809844, WhatsApp: +13530599844
We look forward to working hand in hand with friends from all walks of life to create a better tomorrow for the global health industry!